Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (HKG:0874)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
16.76
+0.03 (0.18%)
Apr 29, 2026, 11:34 AM HKT
0.12%
Market Cap 40.67B
Revenue (ttm) 89.18B
Net Income (ttm) 3.35B
Shares Out n/a
EPS (ttm) 2.06
PE Ratio 12.15
Forward PE 12.57
Dividend 0.88 (5.22%)
Ex-Dividend Date Aug 29, 2025
Volume 299,285
Average Volume 1,463,485
Open 16.73
Previous Close 16.73
Day's Range 16.72 - 16.87
52-Week Range 16.47 - 20.40
Beta 0.35
RSI 38.44
Earnings Date Apr 27, 2026

About HKG:0874

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited engages in the pharmaceutical and healthcare industry in the People’s Republic of China and internationally. The company operates through Modern Chinese Medicine Business, Chemical Pharmaceutical Technology Business, Natural Beverage Business, Pharmaceutical Commercial Business, and Other segments. It is involved in the research, development, manufacturing, and sale of chemical drugs, chemical raw materials, and chemical raw material intermediates; and research, development, productio... [Read more]

Sector Healthcare
Founded 1997
Employees 27,057
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 0874
Full Company Profile

Financial Performance

In 2025, HKG:0874's revenue was 77.66 billion, an increase of 3.55% compared to the previous year's 74.99 billion. Earnings were 2.98 billion, an increase of 5.21%.

Financial numbers in CNY

News

There is no news available yet.